BIO-RAD LABS INC.DL-,0001
BIO-RAD LABS INC.DL-,0001/ US0905722072 /
BUWA
|
27/09/2024 17:13:51
|
Chg.
+1.900
|
Volume |
Bid17:29:13 |
Ask17:29:13 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
298.600EUR
|
+0.64%
|
-
Turnover: - |
297.400Bid Size: 39 |
300.100Ask Size: 39 |
6.84 bill.EUR |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-21.82 USD |
-82.08% |
| EPS Diluted: |
-21.82 USD |
-82.08% |
| Revenues per Share: |
114.05 USD |
-0.20% |
| Book Value per Share: |
373.19 USD |
-4.83% |
| Cash Flow per Share: |
16.01 USD |
101.90% |
| Dividend per Share: |
- USD |
- |
| Total |
in mill. |
|
| Revenues: |
2,671.26 USD |
-4.67% |
| Net Income: |
-637.30 USD |
-82.43% |
| Operating Cash Flow: |
374.90 USD |
- |
| Cash and Cash Equivalents: |
403.82 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
2.94 |
2.83 |
| P/BV ratio: |
0.90 |
0.87 |
| P/CF Ratio: |
20.97 |
20.17 |
| PEG: |
0.19 |
- |
| Earnings Yield: |
-6.50% |
-6.76% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
6.84 bill. EUR |
6.85 bill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
- EUR |
- EUR |
| Shares Outstanding: |
22.79 mill. |
|
Profitability
| Gross Profit Margin: |
53.42% |
| EBIT Margin: |
12.65% |
| Net Profit Margin: |
-23.86% |
| Return on Equity: |
-7.29% |
| Return on Assets: |
-5.18% |
Financial Strength
| Liquidity I / Cash Ratio: |
0.77% |
| Liquidity II / Quick Ratio: |
1.71% |
| Liquidity III / Current Ratio: |
5.83% |
| Debt / Equity Ratio: |
0.14% |
| Dynam. Debt / Equity Ratio: |
949.04% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
31/12/2023 |
| Accounting Standard: |
US GAAP |
